The company is an international enterprise group specializing in R&D, innovation and industrialization of dietary nutritional supplement products. The company continues to provide original and customized nutritional ingredients and formulation products to the global dietary nutritional supplement industry based on scientific research and clinical trials. The main products are nutritional raw products and glucosamine. The company's Stocks were listed on the main board of the Shanghai Stock Exchange on July 23, 2025.
相关临床试验
0
0 进行中
药物批准
1
批准总数
监管机构
1
监管机构数
成立时间
2002
暂无试验阶段数据
暂无试验数据
暂无试验数据
暂无资讯文章